CClinicalTrials.gg
CompletedNCT02558166Updated May 10, 2016

Renal Resistive Index in Patients With Shock

An observational study in Hypovolemic Shock, Cardiogenic Shock and Septic Shock, sponsored by Amsterdam UMC, location VUmc. Completed at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-05-10.

Sponsored by Amsterdam UMC, location VUmc · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
92
Ages
18 Years and older
Sex
All
01

Study summary

This study consists of two substudies.

The first substudy:

'Renal resistive index in critically ill patients with cardiogenic and septic shock'

Design: cross-sectional observational

Aim of this project is:

  1. to determine whether critically ill patients with cardiogenic and septic shock have an elevated Renal Resistive Index and
  2. to determine whether Renal Resistive Index differs between cardiogenic/hypovolemic shock and shock due to sepsis/systemic inflammation (SIRS)
  3. to determine the relation between the (change in) renal vascular resistance and

    • Markers of the systemic - and the microcirculation
    • Fluid status as quantified by bioimpedance analysis
    • Concomitant renal function

The second substudy:

'Predictive value of the Renal Resistive Index on ICU admission and its course for the development of acute kidney injury in critically ill patients with cardiogenic and septic shock'

Design: longitudinal observational

The aim of this project is:

  1. to determine whether the renal resistance index on admission to the intensive care unit can predict the development of acute kidney injury (AKI) in critically ill patients with shock
  2. to investigate if the renal resistance index on admission to the intensive care unit is an independent predictor of the development of AKI or depends on the severity and duration of shock and other known risk factors of AKI such as comorbidity and use of nephrotoxic drugs

Aim of the large research project is to determine whether the Renal Resistive Index could become a monitoring tool for intervention studies aiming to prevent acute kidney injury or protect the kidney.

Read the detailed description

Acute Kidney Injury (AKI) is a severe complication developing in intensive care patients as a result of hypovolemic, cardiogenic or septic shock. It is defined by an abrupt decrease in kidney function. It encompasses both direct injury to the kidney as well as acute impairment of function, including decreased glomerular filtration rate (GFR). Its prevention is crucial because AKI increases morbidity and mortality (1). Mechanisms comprise ischemia/reperfusion, oxidative stress, inflammation and toxicity (2).The common pathophysiological pathway includes endothelial damage to microvessels leading to impaired macro- and microvascular flow and this will aggravate ischemia (3).

Up to now, much controversy exists about

  • the changes in renal blood flow during different kinds of shock
  • the relation between renal blood flow, glomerular filtration rate and the development of AKI
  • the relation between renal blood flow and markers of the systemic and microcirculation

In this prospective observational study, three study measurement will be performed in two groups of critically ill patients (shock and no shock).

  1. The Renal Resistive Index (RRI) will be determined using Renal Doppler Ultrasound . The renal resistive index (RRI) is a sonographic index assessing resistance of the intrarenal arcuate or interlobar arteries and is used to assess renal arterial disease. It is measured as RRI = (peak systolic velocity - end diastolic velocity)/peak systolic velocity. The normal value is ≈ 0,60, with 0,70 being around the upper limits of normal.
  2. The sublingual microcirculation will be quantified using side stream dark field imaging (SDF)
  3. Fluid status will be determined by Bioelectrical impedance analysis (BIA) using the Akern device.

In addition, routinely measured markers of circulation, renal function and fluid balance will be collected for analysis.

02

Conditions studied

  • Hypovolemic Shock
  • Cardiogenic Shock
  • Septic Shock
  • Kidney Failure, Acute

Keywords

  • Acute Kidney Injury (AKI)
  • Renal Resistive Index (RRI)
03

In context

Renal Insufficiency

1,995 studies on the registry are indexed under Renal Insufficiency; 173 are open to participants now.

This study's enrollment of 92 is below the median of 149 across 394 observational studies indexed under Renal Insufficiency.

Browse Renal Insufficiency studies →

Lead sponsor

Amsterdam UMC, location VUmc is the lead sponsor of 302 studies on the registry; 84 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult patients, admitted tot the Intensive Care Unit (ICU)

Variables will be measured in a population of 80 adult patients admitted tot the Intensive Care Unit. This group consists of two groups of 40 patients. The first group consists of 40 patients with cardiogenic or septic shock, the second group will be the control group being intensive care patients without shock. The patients with shock are at increased risk for developing Acute Kidney Injury (AKI).

Inclusion criteria

First group (patients with shock):

  • Critically ill patients admitted to the intensive care unit (ICU) with cardiogenic shock or shock due to sepsis/SIRS or hemorrhage
  • Age > 18 years
  • Noradrenalin support
  • ICU admission \< 24 hours
  • Signed informed consent

Second group (patients without shock):

  • Critically ill patients admitted to the intensive care unit (ICU) without shock, without vasopressor support and without fluid-dependent circulation
  • Age > 18 years
  • ICU admission \< 24-h
  • Signed informed consent

In both groups, written consent will be obtained if and when the patients are awake and able to communicate ('deferred consent')

Exclusion criteria

Exclusion Criteria:

  • Severe pre-admission chronic renal insufficiency (eGFR \< 30 ml/min)
  • Dialysis dependency
  • Renal transplantation
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
92 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients with shock

    Critically ill patients admitted to the intensive care unit (ICU) * with shock due sepsis/SIRS, cardiac failure or hemorrhage * age \> 18 years, * noradrenalin support * \< 24 hours of ICU admission * Signed informed consent

  • Patients without shock

    Critically ill patients admitted to the intensive care unit (ICU) * without shock, without vasopressor support and without fluid dependent circulation * age \> 18 years * \< 24 hours of ICU admission * Signed informed consent

06

What researchers measure

Primary outcomes

  1. renal resistive index (RRI)

    Time frame: 1 week

Secondary outcomes

  1. Creatine clearance (marker of GFR)

    Time frame: 1 week

07

Study locations

1 site
  • VU Medical Center
    Amsterdam, Noord-Holland 1081 HV, Netherlands
08

References and documents

Publications

  • Hoste EA, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med. 2008 Apr;36(4 Suppl):S146-51. doi: 10.1097/CCM.0b013e318168c590. PubMed 18382186 ↗
  • Basile DP, Anderson MD, Sutton TA. Pathophysiology of acute kidney injury. Compr Physiol. 2012 Apr;2(2):1303-53. doi: 10.1002/cphy.c110041. PubMed 23798302 ↗
  • Gomez H, Ince C, De Backer D, Pickkers P, Payen D, Hotchkiss J, Kellum JA. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock. 2014 Jan;41(1):3-11. doi: 10.1097/SHK.0000000000000052. PubMed 24346647 ↗
  • De Backer D, Orbegozo Cortes D, Donadello K, Vincent JL. Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. Virulence. 2014 Jan 1;5(1):73-9. doi: 10.4161/viru.26482. Epub 2013 Sep 25. PubMed 24067428 ↗
  • Darmon M, Schortgen F, Vargas F, Liazydi A, Schlemmer B, Brun-Buisson C, Brochard L. Diagnostic accuracy of Doppler renal resistive index for reversibility of acute kidney injury in critically ill patients. Intensive Care Med. 2011 Jan;37(1):68-76. doi: 10.1007/s00134-010-2050-y. Epub 2010 Sep 23. PubMed 20862450 ↗
  • Schnell D, Deruddre S, Harrois A, Pottecher J, Cosson C, Adoui N, Benhamou D, Vicaut E, Azoulay E, Duranteau J. Renal resistive index better predicts the occurrence of acute kidney injury than cystatin C. Shock. 2012 Dec;38(6):592-7. doi: 10.1097/SHK.0b013e318271a39c. PubMed 23042202 ↗
  • Dewitte A, Coquin J, Meyssignac B, Joannes-Boyau O, Fleureau C, Roze H, Ripoche J, Janvier G, Combe C, Ouattara A. Doppler resistive index to reflect regulation of renal vascular tone during sepsis and acute kidney injury. Crit Care. 2012 Sep 12;16(5):R165. doi: 10.1186/cc11517. PubMed 22971333 ↗
  • Haitsma Mulier JLG, Rozemeijer S, Rottgering JG, Spoelstra-de Man AME, Elbers PWG, Tuinman PR, de Waard MC, Oudemans-van Straaten HM. Renal resistive index as an early predictor and discriminator of acute kidney injury in critically ill patients; A prospective observational cohort study. PLoS One. 2018 Jun 11;13(6):e0197967. doi: 10.1371/journal.pone.0197967. eCollection 2018. PubMed 29889830 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 10, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02558166
Lead sponsor
Amsterdam UMC, location VUmc
Responsible party
H.M. Oudemans-van Straaten, MD, PhD (Prof. Dr., Amsterdam UMC, location VUmc) — Principal investigator
First posted
Sep 23, 2015
Start date
Aug 2015
Primary completion
Jan 2016
Completion
Feb 2016
Last update
May 10, 2016

Study contacts

Heleen M. Oudemans, Prof. Dr.
study director · Amsterdam UMC, location VUmc

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion